The impact of the Cannabis Act (CAC) and the COVID-19 pandemic on substance-related disorders among pregnant women in Quebec.
German antibody company secures €63M for autoimmune disease program
Sign up for free to read a limited number of articles each month. Pick what newsletters get delivered to your inbox each week. Biopharma ENDPOINTS